Alector vs ANI Pharmaceuticals
Alector vs ANI Pharmaceuticals, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alector is on 55/100 and ANI Pharmaceuticals on 49/100.
Where each one leads
Alector
- our overall score: 55/100 against 49/100
- agent readiness: 50/100 against 31/100
ANI Pharmaceuticals
- headcount: 707 against 151
- funding raised: $671M against $163M
- LinkedIn following: 31,660 against 20,574
At a glance
| Measure | Alector | ANI Pharmaceuticals |
|---|---|---|
| What it is | Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases. | Diversified biopharmaceutical company focused on rare diseases, generics, and established brands. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, Pharmaceuticals, Rare Disease, Generics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software | hardware | services | marketplace | platform |
| Founded | 2013 | 1996 |
| Headquarters | South San Francisco, United States | Baudette, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Alector | ANI Pharmaceuticals |
|---|---|---|
| Employees | 151 | 707 |
| Headcount growthLast 12 months | Not published | +95.8% |
| Total funding | $163M | $671M |
| Latest round | Series E | Acquisition |
| LinkedIn followers | 20,574 | 31,660 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alector | ANI Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 49/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | 10/100 |
| Search visibility | 32/100 | 23/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 54/100 | 56/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alector | ANI Pharmaceuticals |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery, Bootstrap |
| Analytics | Google Tag Manager | Google Analytics 4 |
Alector vs ANI Pharmaceuticals: common questions
Which is better, Alector or ANI Pharmaceuticals?
On our 0-100 score Alector rates higher (55/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Alector and ANI Pharmaceuticals compare on the numbers?
Alector leads on our overall score (55/100 against 49/100), agent readiness (50/100 against 31/100). ANI Pharmaceuticals leads on headcount (707 against 151), funding raised ($671M against $163M), LinkedIn following (31,660 against 20,574).
Read the full Alector review and pricing or the ANI Pharmaceuticals review and pricing. You can also browse other Alector alternatives we track.